Sailish Honap

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 21

Top Topics

Randomized Controlled Trial

Ulcerative Colitis

Top Venues

Alimentary pharmacology & therapeutics

Frontline gastroenterology

Nature reviews. Drug discovery

Therapeutic advances in gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Léa Sequier, Bénédicte Caron, Damien Loeuille, Sailish Honap, Vipul Jairath, Patrick Netter, Silvio Danese, Jean Sibilia, Laurent Peyrin Biroulet
Systematic review: Methotrexate-A poorly understood and underused medication in inflammatory bowel disease. Alimentary pharmacology & therapeutics 60 (6) (2024)
Sailish Honap, Vipul Jairath, Silvio Danese, Laurent Peyrin Biroulet
Navigating the complexities of drug development for inflammatory bowel disease. Nature reviews. Drug discovery 23 (7) (2024)
Jennie Clough, Michael Colwill, Andrew Poullis, Richard Pollok, Kamal Patel, Sailish Honap
Biomarkers in inflammatory bowel disease: a practical guide. Therapeutic advances in gastroenterology 17 (2024)
Jennie Clough, Michael Colwill, Andrew Poullis, Richard Pollok, Kamal Patel, Sailish Honap
Biomarkers in inflammatory bowel disease: a practical guide. Therapeutic advances in gastroenterology 17 (2024)
Léa Sequier, Bénédicte Caron, Damien Loeuille, Sailish Honap, Vipul Jairath, Patrick Netter, Silvio Danese, Jean Sibilia, Laurent Peyrin Biroulet
Systematic review: Methotrexate-A poorly understood and underused medication in inflammatory bowel disease. Alimentary pharmacology & therapeutics (2024)
Sailish Honap, Vipul Jairath, Silvio Danese, Laurent Peyrin Biroulet
Navigating the complexities of drug development for inflammatory bowel disease. Nature reviews. Drug discovery 23 (7) (2024)
Sailish Honap, Vipul Jairath, Silvio Danese, Laurent Peyrin Biroulet
Navigating the complexities of drug development for inflammatory bowel disease. Nature reviews. Drug discovery (2024)
Sailish Honap, Vipul Jairath, Bruce E Sands, Parambir S Dulai, Marjorie Costa Argollo, Laurent Peyrin Biroulet
Acute severe ulcerative colitis trials: the past, the present and the future. Gut (2024)
Sailish Honap, Silvio Danese, Laurent Peyrin-Biroulet
Target Trial Emulation: Improving the Quality of Observational Studies in Inflammatory Bowel Disease Using the Principles of Randomized Trials. Inflammatory bowel diseases (2024)
Sailish Honap, Nelly Agrinier, Silvio Danese, Laurent Peyrin Biroulet
Disease prevention trials in IBD: feasibility to future outlook. Nature reviews. Gastroenterology & hepatology (2024)
Maria Jose Temido, Sailish Honap, Silvio Danese, Vipul Jairath, Fernando Magro, Francisco Portela, Laurent Peyrin-Biroulet
Nested Randomized Controlled Trials in Large Databases: An Opportunity for Inflammatory Bowel Disease? Journal of Crohn's & colitis (2024)
Sailish Honap, Vipul Jairath, Silvio Danese, Laurent Peyrin Biroulet
Navigating the complexities of drug development for inflammatory bowel disease. Nature reviews. Drug discovery 23 (7) (2024)
Sailish Honap, Laurent Peyrin Biroulet
Review article: Externally derived control arms-An opportunity for clinical trials in inflammatory bowel disease? Alimentary pharmacology & therapeutics (2023)
Sailish Honap, Alexandra Agorogianni, Michael J Colwill, Sonia Kalyanji Mehta, Fiona Donovan, Richard C G Pollok, Andrew Poullis, Kamal V Patel
JAK inhibitors for inflammatory bowel disease: recent advances. Frontline gastroenterology 15 (1) (2023)
Sailish Honap, Alexandra Agorogianni, Michael J Colwill, Sonia Kalyanji Mehta, Fiona Donovan, Richard C G Pollok, Andrew Poullis, Kamal V Patel
JAK inhibitors for inflammatory bowel disease: recent advances. Frontline gastroenterology 15 (1) (2023)
Sailish Honap, Lulia Al-Hillawi, Samantha Baillie, Aaron Bancil, Lawrence Matini, Rebecca Lau, Klaartje Bel Kok, Kamal V Patel, Alissa Walsh, Peter M Irving, Mark A Samaan
Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study. Frontline gastroenterology 13 (6) (2022)
Susanna Meade, Emma Routledge, Esha Sharma, Sailish Honap, Shuvra Ray, Simon H C Anderson, Jeremy Sanderson, Joel Mawdsley, Peter M Irving, Mark A Samaan
How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes? Frontline gastroenterology 14 (4) (2022)
Sailish Honap, Robin J Dart, Mark A Samaan
Editorial: protecting hypoxia-inducible factor-1α and gut integrity with GB004-a promising therapeutic approach for ulcerative colitis? Alimentary pharmacology & therapeutics 55 (6) (2022)
Sailish Honap, Polychronis Pavlidis, Peter M Irving
Editorial: is tofacitinib another rescue option for acute severe ulcerative colitis? Alimentary pharmacology & therapeutics 54 (3) (2021)
Sailish Honap, Susanna Meade, Hajir Ibraheim, Peter M Irving, Michael P Jones, Mark A Samaan
Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Digestive diseases and sciences (2021)
Sailish Honap, Emma Johnston, Gaurav Agrawal, Bahij Al-Hakim, John Hermon-Taylor, Jeremy Sanderson
Anti- Mycobacterium paratuberculosis (MAP) therapy for Crohn's disease: an overview and update. Frontline gastroenterology 12 (5) (2020)